REQUEST A DEMO
Total
USD $0.00
Search more companies

Everest Medicines (Singapore) Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Everest Medicines (Singapore) Pte. Ltd. Profile Updated: December 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western); Secondary Business Activity: research and experimental development on medical and veterinary sciences

Legal Address
36 Robinson Road, #20-01, City House, Singapore 068877
Singapore; Singapore; Postal Code: 068877

Contact Details: Purchase the Everest Medicines (Singapore) Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Everest Medicines (Singapore) Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Everest Medicines (Singapore) Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Everest Medicines (Singapore) Pte. Ltd. report to view the information.
Incorporation Date:
November 22, 2018
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Everest Medicines (Singapore) Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
462.52%
Total operating revenue
462.52%
Net Profit/Loss for the Period
26.26%
Total Assets
13.6%
Total Equity
-18.85%
Net Profit Margin
261.52%
Return on Equity (ROE)
7%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?